Medtronic's ATS acquisition
This article was originally published in The Gray Sheet
Executive Summary
Transaction is expected to close "on or about Aug. 12" following shareholder approval of the $370 million deal, ATS Medical reports Aug. 5. Medtronic announced plans to acquire ATS April 29 (1"The Gray Sheet" May 3, 2010)
You may also be interested in...
Medtronic Shores Up Tissue Valve Portfolio With ATS Medical Acquisition
Medtronic will expand its pericardial tissue heart valve offerings and further strengthen its cardiovascular business through its $370 million acquisition of ATS Medical, announced April 29
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.